1 Study Coverage
1.1 Antiblocking Agents Product Introduction
1.2 Market by Type
1.2.1 Global Antiblocking Agents Market Size by Type, 2017 VS 2021 VS 2028
1.2.2 Organic
1.2.3 Inorganic
1.3 Market by Application
1.3.1 Global Antiblocking Agents Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 PE Films
1.3.3 PP Films
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Antiblocking Agents Production
2.1 Global Antiblocking Agents Production Capacity (2017-2028)
2.2 Global Antiblocking Agents Production by Region: 2017 VS 2021 VS 2028
2.3 Global Antiblocking Agents Production by Region
2.3.1 Global Antiblocking Agents Historic Production by Region (2017-2022)
2.3.2 Global Antiblocking Agents Forecasted Production by Region (2023-2028)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Global Antiblocking Agents Sales in Volume & Value Estimates and Forecasts
3.1 Global Antiblocking Agents Sales Estimates and Forecasts 2017-2028
3.2 Global Antiblocking Agents Revenue Estimates and Forecasts 2017-2028
3.3 Global Antiblocking Agents Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global Antiblocking Agents Sales by Region
3.4.1 Global Antiblocking Agents Sales by Region (2017-2022)
3.4.2 Global Sales Antiblocking Agents by Region (2023-2028)
3.5 Global Antiblocking Agents Revenue by Region
3.5.1 Global Antiblocking Agents Revenue by Region (2017-2022)
3.5.2 Global Antiblocking Agents Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global Antiblocking Agents Production Capacity by Manufacturers
4.2 Global Antiblocking Agents Sales by Manufacturers
4.2.1 Global Antiblocking Agents Sales by Manufacturers (2017-2022)
4.2.2 Global Antiblocking Agents Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Antiblocking Agents in 2021
4.3 Global Antiblocking Agents Revenue by Manufacturers
4.3.1 Global Antiblocking Agents Revenue by Manufacturers (2017-2022)
4.3.2 Global Antiblocking Agents Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by Antiblocking Agents Revenue in 2021
4.4 Global Antiblocking Agents Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Antiblocking Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Antiblocking Agents Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Antiblocking Agents Sales by Type
5.1.1 Global Antiblocking Agents Historical Sales by Type (2017-2022)
5.1.2 Global Antiblocking Agents Forecasted Sales by Type (2023-2028)
5.1.3 Global Antiblocking Agents Sales Market Share by Type (2017-2028)
5.2 Global Antiblocking Agents Revenue by Type
5.2.1 Global Antiblocking Agents Historical Revenue by Type (2017-2022)
5.2.2 Global Antiblocking Agents Forecasted Revenue by Type (2023-2028)
5.2.3 Global Antiblocking Agents Revenue Market Share by Type (2017-2028)
5.3 Global Antiblocking Agents Price by Type
5.3.1 Global Antiblocking Agents Price by Type (2017-2022)
5.3.2 Global Antiblocking Agents Price Forecast by Type (2023-2028)
6 Market Size by Application
6.1 Global Antiblocking Agents Sales by Application
6.1.1 Global Antiblocking Agents Historical Sales by Application (2017-2022)
6.1.2 Global Antiblocking Agents Forecasted Sales by Application (2023-2028)
6.1.3 Global Antiblocking Agents Sales Market Share by Application (2017-2028)
6.2 Global Antiblocking Agents Revenue by Application
6.2.1 Global Antiblocking Agents Historical Revenue by Application (2017-2022)
6.2.2 Global Antiblocking Agents Forecasted Revenue by Application (2023-2028)
6.2.3 Global Antiblocking Agents Revenue Market Share by Application (2017-2028)
6.3 Global Antiblocking Agents Price by Application
6.3.1 Global Antiblocking Agents Price by Application (2017-2022)
6.3.2 Global Antiblocking Agents Price Forecast by Application (2023-2028)
7 North America
7.1 North America Antiblocking Agents Market Size by Type
7.1.1 North America Antiblocking Agents Sales by Type (2017-2028)
7.1.2 North America Antiblocking Agents Revenue by Type (2017-2028)
7.2 North America Antiblocking Agents Market Size by Application
7.2.1 North America Antiblocking Agents Sales by Application (2017-2028)
7.2.2 North America Antiblocking Agents Revenue by Application (2017-2028)
7.3 North America Antiblocking Agents Sales by Country
7.3.1 North America Antiblocking Agents Sales by Country (2017-2028)
7.3.2 North America Antiblocking Agents Revenue by Country (2017-2028)
7.3.3 United States
7.3.4 Canada
8 Europe
8.1 Europe Antiblocking Agents Market Size by Type
8.1.1 Europe Antiblocking Agents Sales by Type (2017-2028)
8.1.2 Europe Antiblocking Agents Revenue by Type (2017-2028)
8.2 Europe Antiblocking Agents Market Size by Application
8.2.1 Europe Antiblocking Agents Sales by Application (2017-2028)
8.2.2 Europe Antiblocking Agents Revenue by Application (2017-2028)
8.3 Europe Antiblocking Agents Sales by Country
8.3.1 Europe Antiblocking Agents Sales by Country (2017-2028)
8.3.2 Europe Antiblocking Agents Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific Antiblocking Agents Market Size by Type
9.1.1 Asia Pacific Antiblocking Agents Sales by Type (2017-2028)
9.1.2 Asia Pacific Antiblocking Agents Revenue by Type (2017-2028)
9.2 Asia Pacific Antiblocking Agents Market Size by Application
9.2.1 Asia Pacific Antiblocking Agents Sales by Application (2017-2028)
9.2.2 Asia Pacific Antiblocking Agents Revenue by Application (2017-2028)
9.3 Asia Pacific Antiblocking Agents Sales by Region
9.3.1 Asia Pacific Antiblocking Agents Sales by Region (2017-2028)
9.3.2 Asia Pacific Antiblocking Agents Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 China Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
10 Latin America
10.1 Latin America Antiblocking Agents Market Size by Type
10.1.1 Latin America Antiblocking Agents Sales by Type (2017-2028)
10.1.2 Latin America Antiblocking Agents Revenue by Type (2017-2028)
10.2 Latin America Antiblocking Agents Market Size by Application
10.2.1 Latin America Antiblocking Agents Sales by Application (2017-2028)
10.2.2 Latin America Antiblocking Agents Revenue by Application (2017-2028)
10.3 Latin America Antiblocking Agents Sales by Country
10.3.1 Latin America Antiblocking Agents Sales by Country (2017-2028)
10.3.2 Latin America Antiblocking Agents Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Antiblocking Agents Market Size by Type
11.1.1 Middle East and Africa Antiblocking Agents Sales by Type (2017-2028)
11.1.2 Middle East and Africa Antiblocking Agents Revenue by Type (2017-2028)
11.2 Middle East and Africa Antiblocking Agents Market Size by Application
11.2.1 Middle East and Africa Antiblocking Agents Sales by Application (2017-2028)
11.2.2 Middle East and Africa Antiblocking Agents Revenue by Application (2017-2028)
11.3 Middle East and Africa Antiblocking Agents Sales by Country
11.3.1 Middle East and Africa Antiblocking Agents Sales by Country (2017-2028)
11.3.2 Middle East and Africa Antiblocking Agents Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 UAE
12 Corporate Profiles
12.1 Evonik
12.1.1 Evonik Corporation Information
12.1.2 Evonik Overview
12.1.3 Evonik Antiblocking Agents Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 Evonik Antiblocking Agents Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Evonik Recent Developments
12.2 WR Grace
12.2.1 WR Grace Corporation Information
12.2.2 WR Grace Overview
12.2.3 WR Grace Antiblocking Agents Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 WR Grace Antiblocking Agents Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 WR Grace Recent Developments
12.3 Minerals Technologies
12.3.1 Minerals Technologies Corporation Information
12.3.2 Minerals Technologies Overview
12.3.3 Minerals Technologies Antiblocking Agents Sales, Price, Revenue and Gross Margin (2017-2022)
12.3.4 Minerals Technologies Antiblocking Agents Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Minerals Technologies Recent Developments
12.4 Croda
12.4.1 Croda Corporation Information
12.4.2 Croda Overview
12.4.3 Croda Antiblocking Agents Sales, Price, Revenue and Gross Margin (2017-2022)
12.4.4 Croda Antiblocking Agents Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Croda Recent Developments
12.5 PQ Corporation
12.5.1 PQ Corporation Corporation Information
12.5.2 PQ Corporation Overview
12.5.3 PQ Corporation Antiblocking Agents Sales, Price, Revenue and Gross Margin (2017-2022)
12.5.4 PQ Corporation Antiblocking Agents Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 PQ Corporation Recent Developments
12.6 Madhu Silica
12.6.1 Madhu Silica Corporation Information
12.6.2 Madhu Silica Overview
12.6.3 Madhu Silica Antiblocking Agents Sales, Price, Revenue and Gross Margin (2017-2022)
12.6.4 Madhu Silica Antiblocking Agents Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Madhu Silica Recent Developments
12.7 Solvay
12.7.1 Solvay Corporation Information
12.7.2 Solvay Overview
12.7.3 Solvay Antiblocking Agents Sales, Price, Revenue and Gross Margin (2017-2022)
12.7.4 Solvay Antiblocking Agents Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 Solvay Recent Developments
12.8 Fuji Silysia
12.8.1 Fuji Silysia Corporation Information
12.8.2 Fuji Silysia Overview
12.8.3 Fuji Silysia Antiblocking Agents Sales, Price, Revenue and Gross Margin (2017-2022)
12.8.4 Fuji Silysia Antiblocking Agents Product Model Numbers, Pictures, Descriptions and Specifications
12.8.5 Fuji Silysia Recent Developments
12.9 IQE Group
12.9.1 IQE Group Corporation Information
12.9.2 IQE Group Overview
12.9.3 IQE Group Antiblocking Agents Sales, Price, Revenue and Gross Margin (2017-2022)
12.9.4 IQE Group Antiblocking Agents Product Model Numbers, Pictures, Descriptions and Specifications
12.9.5 IQE Group Recent Developments
12.10 Tosoh Silica
12.10.1 Tosoh Silica Corporation Information
12.10.2 Tosoh Silica Overview
12.10.3 Tosoh Silica Antiblocking Agents Sales, Price, Revenue and Gross Margin (2017-2022)
12.10.4 Tosoh Silica Antiblocking Agents Product Model Numbers, Pictures, Descriptions and Specifications
12.10.5 Tosoh Silica Recent Developments
12.11 NYACOL Nano Technologies
12.11.1 NYACOL Nano Technologies Corporation Information
12.11.2 NYACOL Nano Technologies Overview
12.11.3 NYACOL Nano Technologies Antiblocking Agents Sales, Price, Revenue and Gross Margin (2017-2022)
12.11.4 NYACOL Nano Technologies Antiblocking Agents Product Model Numbers, Pictures, Descriptions and Specifications
12.11.5 NYACOL Nano Technologies Recent Developments
12.12 S-Chemtech
12.12.1 S-Chemtech Corporation Information
12.12.2 S-Chemtech Overview
12.12.3 S-Chemtech Antiblocking Agents Sales, Price, Revenue and Gross Margin (2017-2022)
12.12.4 S-Chemtech Antiblocking Agents Product Model Numbers, Pictures, Descriptions and Specifications
12.12.5 S-Chemtech Recent Developments
12.13 Baerlocher
12.13.1 Baerlocher Corporation Information
12.13.2 Baerlocher Overview
12.13.3 Baerlocher Antiblocking Agents Sales, Price, Revenue and Gross Margin (2017-2022)
12.13.4 Baerlocher Antiblocking Agents Product Model Numbers, Pictures, Descriptions and Specifications
12.13.5 Baerlocher Recent Developments
12.14 Imerys
12.14.1 Imerys Corporation Information
12.14.2 Imerys Overview
12.14.3 Imerys Antiblocking Agents Sales, Price, Revenue and Gross Margin (2017-2022)
12.14.4 Imerys Antiblocking Agents Product Model Numbers, Pictures, Descriptions and Specifications
12.14.5 Imerys Recent Developments
12.15 Hoffmann Mineral
12.15.1 Hoffmann Mineral Corporation Information
12.15.2 Hoffmann Mineral Overview
12.15.3 Hoffmann Mineral Antiblocking Agents Sales, Price, Revenue and Gross Margin (2017-2022)
12.15.4 Hoffmann Mineral Antiblocking Agents Product Model Numbers, Pictures, Descriptions and Specifications
12.15.5 Hoffmann Mineral Recent Developments
12.16 EP Mineral
12.16.1 EP Mineral Corporation Information
12.16.2 EP Mineral Overview
12.16.3 EP Mineral Antiblocking Agents Sales, Price, Revenue and Gross Margin (2017-2022)
12.16.4 EP Mineral Antiblocking Agents Product Model Numbers, Pictures, Descriptions and Specifications
12.16.5 EP Mineral Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Antiblocking Agents Industry Chain Analysis
13.2 Antiblocking Agents Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Antiblocking Agents Production Mode & Process
13.4 Antiblocking Agents Sales and Marketing
13.4.1 Antiblocking Agents Sales Channels
13.4.2 Antiblocking Agents Distributors
13.5 Antiblocking Agents Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Antiblocking Agents Industry Trends
14.2 Antiblocking Agents Market Drivers
14.3 Antiblocking Agents Market Challenges
14.4 Antiblocking Agents Market Restraints
15 Key Finding in The Global Antiblocking Agents Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Antiblocking Agents Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Organic
Table 3. Major Manufacturers of Inorganic
Table 4. Global Antiblocking Agents Market Size Growth Rate by Application, 2017 VS 2021 2028 (US$ Million)
Table 5. Global Antiblocking Agents Production by Region: 2017 VS 2021 VS 2028 (Kiloton)
Table 6. Global Antiblocking Agents Production by Region (2017-2022) & (Kiloton)
Table 7. Global Antiblocking Agents Production Market Share by Region (2017-2022)
Table 8. Global Antiblocking Agents Production by Region (2023-2028) & (Kiloton)
Table 9. Global Antiblocking Agents Production Market Share by Region (2023-2028)
Table 10. Global Antiblocking Agents Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 11. Global Antiblocking Agents Sales by Region (2017-2022) & (Kiloton)
Table 12. Global Antiblocking Agents Sales Market Share by Region (2017-2022)
Table 13. Global Antiblocking Agents Sales by Region (2023-2028) & (Kiloton)
Table 14. Global Antiblocking Agents Sales Market Share by Region (2023-2028)
Table 15. Global Antiblocking Agents Revenue by Region (2017-2022) & (US$ Million)
Table 16. Global Antiblocking Agents Revenue Market Share by Region (2017-2022)
Table 17. Global Antiblocking Agents Revenue by Region (2023-2028) & (US$ Million)
Table 18. Global Antiblocking Agents Revenue Market Share by Region (2023-2028)
Table 19. Global Antiblocking Agents Production Capacity by Manufacturers (2017-2022) & (Kiloton)
Table 20. Global Antiblocking Agents Capacity Market Share by Manufacturers (2017-2022)
Table 21. Global Antiblocking Agents Sales by Manufacturers (2017-2022) & (Kiloton)
Table 22. Global Antiblocking Agents Sales Market Share by Manufacturers (2017-2022)
Table 23. Global Antiblocking Agents Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 24. Global Antiblocking Agents Revenue Share by Manufacturers (2017-2022)
Table 25. Antiblocking Agents Price by Manufacturers 2017-2022 (US$/Ton)
Table 26. Global Antiblocking Agents Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 27. Global Antiblocking Agents by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiblocking Agents as of 2021)
Table 28. Antiblocking Agents Manufacturing Base Distribution and Headquarters
Table 29. Manufacturers Antiblocking Agents Product Offered
Table 30. Date of Manufacturers Enter into Antiblocking Agents Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Antiblocking Agents Sales by Type (2017-2022) & (Kiloton)
Table 33. Global Antiblocking Agents Sales by Type (2023-2028) & (Kiloton)
Table 34. Global Antiblocking Agents Sales Share by Type (2017-2022)
Table 35. Global Antiblocking Agents Sales Share by Type (2023-2028)
Table 36. Global Antiblocking Agents Revenue by Type (2017-2022) & (US$ Million)
Table 37. Global Antiblocking Agents Revenue by Type (2023-2028) & (US$ Million)
Table 38. Global Antiblocking Agents Revenue Share by Type (2017-2022)
Table 39. Global Antiblocking Agents Revenue Share by Type (2023-2028)
Table 40. Antiblocking Agents Price by Type (2017-2022) & (US$/Ton)
Table 41. Global Antiblocking Agents Price Forecast by Type (2023-2028) & (US$/Ton)
Table 42. Global Antiblocking Agents Sales by Application (2017-2022) & (Kiloton)
Table 43. Global Antiblocking Agents Sales by Application (2023-2028) & (Kiloton)
Table 44. Global Antiblocking Agents Sales Share by Application (2017-2022)
Table 45. Global Antiblocking Agents Sales Share by Application (2023-2028)
Table 46. Global Antiblocking Agents Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Antiblocking Agents Revenue by Application (2023-2028) & (US$ Million)
Table 48. Global Antiblocking Agents Revenue Share by Application (2017-2022)
Table 49. Global Antiblocking Agents Revenue Share by Application (2023-2028)
Table 50. Antiblocking Agents Price by Application (2017-2022) & (US$/Ton)
Table 51. Global Antiblocking Agents Price Forecast by Application (2023-2028) & (US$/Ton)
Table 52. North America Antiblocking Agents Sales by Type (2017-2022) & (Kiloton)
Table 53. North America Antiblocking Agents Sales by Type (2023-2028) & (Kiloton)
Table 54. North America Antiblocking Agents Revenue by Type (2017-2022) & (US$ Million)
Table 55. North America Antiblocking Agents Revenue by Type (2023-2028) & (US$ Million)
Table 56. North America Antiblocking Agents Sales by Application (2017-2022) & (Kiloton)
Table 57. North America Antiblocking Agents Sales by Application (2023-2028) & (Kiloton)
Table 58. North America Antiblocking Agents Revenue by Application (2017-2022) & (US$ Million)
Table 59. North America Antiblocking Agents Revenue by Application (2023-2028) & (US$ Million)
Table 60. North America Antiblocking Agents Sales by Country (2017-2022) & (Kiloton)
Table 61. North America Antiblocking Agents Sales by Country (2023-2028) & (Kiloton)
Table 62. North America Antiblocking Agents Revenue by Country (2017-2022) & (US$ Million)
Table 63. North America Antiblocking Agents Revenue by Country (2023-2028) & (US$ Million)
Table 64. Europe Antiblocking Agents Sales by Type (2017-2022) & (Kiloton)
Table 65. Europe Antiblocking Agents Sales by Type (2023-2028) & (Kiloton)
Table 66. Europe Antiblocking Agents Revenue by Type (2017-2022) & (US$ Million)
Table 67. Europe Antiblocking Agents Revenue by Type (2023-2028) & (US$ Million)
Table 68. Europe Antiblocking Agents Sales by Application (2017-2022) & (Kiloton)
Table 69. Europe Antiblocking Agents Sales by Application (2023-2028) & (Kiloton)
Table 70. Europe Antiblocking Agents Revenue by Application (2017-2022) & (US$ Million)
Table 71. Europe Antiblocking Agents Revenue by Application (2023-2028) & (US$ Million)
Table 72. Europe Antiblocking Agents Sales by Country (2017-2022) & (Kiloton)
Table 73. Europe Antiblocking Agents Sales by Country (2023-2028) & (Kiloton)
Table 74. Europe Antiblocking Agents Revenue by Country (2017-2022) & (US$ Million)
Table 75. Europe Antiblocking Agents Revenue by Country (2023-2028) & (US$ Million)
Table 76. Asia Pacific Antiblocking Agents Sales by Type (2017-2022) & (Kiloton)
Table 77. Asia Pacific Antiblocking Agents Sales by Type (2023-2028) & (Kiloton)
Table 78. Asia Pacific Antiblocking Agents Revenue by Type (2017-2022) & (US$ Million)
Table 79. Asia Pacific Antiblocking Agents Revenue by Type (2023-2028) & (US$ Million)
Table 80. Asia Pacific Antiblocking Agents Sales by Application (2017-2022) & (Kiloton)
Table 81. Asia Pacific Antiblocking Agents Sales by Application (2023-2028) & (Kiloton)
Table 82. Asia Pacific Antiblocking Agents Revenue by Application (2017-2022) & (US$ Million)
Table 83. Asia Pacific Antiblocking Agents Revenue by Application (2023-2028) & (US$ Million)
Table 84. Asia Pacific Antiblocking Agents Sales by Region (2017-2022) & (Kiloton)
Table 85. Asia Pacific Antiblocking Agents Sales by Region (2023-2028) & (Kiloton)
Table 86. Asia Pacific Antiblocking Agents Revenue by Region (2017-2022) & (US$ Million)
Table 87. Asia Pacific Antiblocking Agents Revenue by Region (2023-2028) & (US$ Million)
Table 88. Latin America Antiblocking Agents Sales by Type (2017-2022) & (Kiloton)
Table 89. Latin America Antiblocking Agents Sales by Type (2023-2028) & (Kiloton)
Table 90. Latin America Antiblocking Agents Revenue by Type (2017-2022) & (US$ Million)
Table 91. Latin America Antiblocking Agents Revenue by Type (2023-2028) & (US$ Million)
Table 92. Latin America Antiblocking Agents Sales by Application (2017-2022) & (Kiloton)
Table 93. Latin America Antiblocking Agents Sales by Application (2023-2028) & (Kiloton)
Table 94. Latin America Antiblocking Agents Revenue by Application (2017-2022) & (US$ Million)
Table 95. Latin America Antiblocking Agents Revenue by Application (2023-2028) & (US$ Million)
Table 96. Latin America Antiblocking Agents Sales by Country (2017-2022) & (Kiloton)
Table 97. Latin America Antiblocking Agents Sales by Country (2023-2028) & (Kiloton)
Table 98. Latin America Antiblocking Agents Revenue by Country (2017-2022) & (US$ Million)
Table 99. Latin America Antiblocking Agents Revenue by Country (2023-2028) & (US$ Million)
Table 100. Middle East and Africa Antiblocking Agents Sales by Type (2017-2022) & (Kiloton)
Table 101. Middle East and Africa Antiblocking Agents Sales by Type (2023-2028) & (Kiloton)
Table 102. Middle East and Africa Antiblocking Agents Revenue by Type (2017-2022) & (US$ Million)
Table 103. Middle East and Africa Antiblocking Agents Revenue by Type (2023-2028) & (US$ Million)
Table 104. Middle East and Africa Antiblocking Agents Sales by Application (2017-2022) & (Kiloton)
Table 105. Middle East and Africa Antiblocking Agents Sales by Application (2023-2028) & (Kiloton)
Table 106. Middle East and Africa Antiblocking Agents Revenue by Application (2017-2022) & (US$ Million)
Table 107. Middle East and Africa Antiblocking Agents Revenue by Application (2023-2028) & (US$ Million)
Table 108. Middle East and Africa Antiblocking Agents Sales by Country (2017-2022) & (Kiloton)
Table 109. Middle East and Africa Antiblocking Agents Sales by Country (2023-2028) & (Kiloton)
Table 110. Middle East and Africa Antiblocking Agents Revenue by Country (2017-2022) & (US$ Million)
Table 111. Middle East and Africa Antiblocking Agents Revenue by Country (2023-2028) & (US$ Million)
Table 112. Evonik Corporation Information
Table 113. Evonik Description and Major Businesses
Table 114. Evonik Antiblocking Agents Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 115. Evonik Antiblocking Agents Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Evonik Recent Development
Table 117. WR Grace Corporation Information
Table 118. WR Grace Description and Major Businesses
Table 119. WR Grace Antiblocking Agents Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 120. WR Grace Antiblocking Agents Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. WR Grace Recent Development
Table 122. Minerals Technologies Corporation Information
Table 123. Minerals Technologies Description and Major Businesses
Table 124. Minerals Technologies Antiblocking Agents Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 125. Minerals Technologies Antiblocking Agents Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Minerals Technologies Recent Development
Table 127. Croda Corporation Information
Table 128. Croda Description and Major Businesses
Table 129. Croda Antiblocking Agents Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 130. Croda Antiblocking Agents Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Croda Recent Development
Table 132. PQ Corporation Corporation Information
Table 133. PQ Corporation Description and Major Businesses
Table 134. PQ Corporation Antiblocking Agents Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 135. PQ Corporation Antiblocking Agents Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. PQ Corporation Recent Development
Table 137. Madhu Silica Corporation Information
Table 138. Madhu Silica Description and Major Businesses
Table 139. Madhu Silica Antiblocking Agents Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 140. Madhu Silica Antiblocking Agents Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Madhu Silica Recent Development
Table 142. Solvay Corporation Information
Table 143. Solvay Description and Major Businesses
Table 144. Solvay Antiblocking Agents Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 145. Solvay Antiblocking Agents Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Solvay Recent Development
Table 147. Fuji Silysia Corporation Information
Table 148. Fuji Silysia Description and Major Businesses
Table 149. Fuji Silysia Antiblocking Agents Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 150. Fuji Silysia Antiblocking Agents Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Fuji Silysia Recent Development
Table 152. IQE Group Corporation Information
Table 153. IQE Group Description and Major Businesses
Table 154. IQE Group Antiblocking Agents Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 155. IQE Group Antiblocking Agents Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. IQE Group Recent Development
Table 157. Tosoh Silica Corporation Information
Table 158. Tosoh Silica Description and Major Businesses
Table 159. Tosoh Silica Antiblocking Agents Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 160. Tosoh Silica Antiblocking Agents Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Tosoh Silica Recent Development
Table 162. NYACOL Nano Technologies Corporation Information
Table 163. NYACOL Nano Technologies Description and Major Businesses
Table 164. NYACOL Nano Technologies Antiblocking Agents Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 165. NYACOL Nano Technologies Antiblocking Agents Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. NYACOL Nano Technologies Recent Development
Table 167. S-Chemtech Corporation Information
Table 168. S-Chemtech Description and Major Businesses
Table 169. S-Chemtech Antiblocking Agents Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 170. S-Chemtech Antiblocking Agents Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. S-Chemtech Recent Development
Table 172. Baerlocher Corporation Information
Table 173. Baerlocher Description and Major Businesses
Table 174. Baerlocher Antiblocking Agents Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 175. Baerlocher Antiblocking Agents Product Model Numbers, Pictures, Descriptions and Specifications
Table 176. Baerlocher Recent Development
Table 177. Imerys Corporation Information
Table 178. Imerys Description and Major Businesses
Table 179. Imerys Antiblocking Agents Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 180. Imerys Antiblocking Agents Product Model Numbers, Pictures, Descriptions and Specifications
Table 181. Imerys Recent Development
Table 182. Hoffmann Mineral Corporation Information
Table 183. Hoffmann Mineral Description and Major Businesses
Table 184. Hoffmann Mineral Antiblocking Agents Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 185. Hoffmann Mineral Antiblocking Agents Product Model Numbers, Pictures, Descriptions and Specifications
Table 186. Hoffmann Mineral Recent Development
Table 187. EP Mineral Corporation Information
Table 188. EP Mineral Description and Major Businesses
Table 189. EP Mineral Antiblocking Agents Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 190. EP Mineral Antiblocking Agents Product Model Numbers, Pictures, Descriptions and Specifications
Table 191. EP Mineral Recent Development
Table 192. Key Raw Materials Lists
Table 193. Raw Materials Key Suppliers Lists
Table 194. Antiblocking Agents Distributors List
Table 195. Antiblocking Agents Customers List
Table 196. Antiblocking Agents Market Trends
Table 197. Antiblocking Agents Market Drivers
Table 198. Antiblocking Agents Market Challenges
Table 199. Antiblocking Agents Market Restraints
Table 200. Research Programs/Design for This Report
Table 201. Key Data Information from Secondary Sources
Table 202. Key Data Information from Primary Sources
List of Figures
Figure 1. Antiblocking Agents Product Picture
Figure 2. Global Antiblocking Agents Market Share by Type in 2021 & 2028
Figure 3. Organic Product Picture
Figure 4. Inorganic Product Picture
Figure 5. Global Antiblocking Agents Market Share by Application in 2021 & 2028
Figure 6. PE Films
Figure 7. PP Films
Figure 8. Others
Figure 9. Antiblocking Agents Report Years Considered
Figure 10. Global Antiblocking Agents Capacity, Production and Utilization (2017-2028) & (Kiloton)
Figure 11. Global Antiblocking Agents Production Market Share by Region in Percentage: 2021 Versus 2028
Figure 12. Global Antiblocking Agents Production Market Share by Region (2017-2022)
Figure 13. Global Antiblocking Agents Production Market Share by Region (2023-2028)
Figure 14. Antiblocking Agents Production Growth Rate in North America (2017-2028) & (Kiloton)
Figure 15. Antiblocking Agents Production Growth Rate in Europe (2017-2028) & (Kiloton)
Figure 16. Antiblocking Agents Production Growth Rate in China (2017-2028) & (Kiloton)
Figure 17. Antiblocking Agents Production Growth Rate in Japan (2017-2028) & (Kiloton)
Figure 18. Global Antiblocking Agents Sales 2017-2028 (Kiloton)
Figure 19. Global Antiblocking Agents Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 20. Global Antiblocking Agents Revenue 2017-2028 (US$ Million)
Figure 21. Global Antiblocking Agents Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 22. Global Antiblocking Agents Sales Market Share by Region (2017-2022)
Figure 23. Global Antiblocking Agents Sales Market Share by Region (2023-2028)
Figure 24. North America Antiblocking Agents Sales YoY (2017-2028) & (Kiloton)
Figure 25. North America Antiblocking Agents Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Europe Antiblocking Agents Sales YoY (2017-2028) & (Kiloton)
Figure 27. Europe Antiblocking Agents Revenue YoY (2017-2028) & (US$ Million)
Figure 28. Asia-Pacific Antiblocking Agents Sales YoY (2017-2028) & (Kiloton)
Figure 29. Asia-Pacific Antiblocking Agents Revenue YoY (2017-2028) & (US$ Million)
Figure 30. Latin America Antiblocking Agents Sales YoY (2017-2028) & (Kiloton)
Figure 31. Latin America Antiblocking Agents Revenue YoY (2017-2028) & (US$ Million)
Figure 32. Middle East & Africa Antiblocking Agents Sales YoY (2017-2028) & (Kiloton)
Figure 33. Middle East & Africa Antiblocking Agents Revenue YoY (2017-2028) & (US$ Million)
Figure 34. The Antiblocking Agents Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 35. The Top 5 and 10 Largest Manufacturers of Antiblocking Agents in the World: Market Share by Antiblocking Agents Revenue in 2021
Figure 36. Antiblocking Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 37. Global Antiblocking Agents Sales Market Share by Type (2017-2028)
Figure 38. Global Antiblocking Agents Revenue Market Share by Type (2017-2028)
Figure 39. Global Antiblocking Agents Sales Market Share by Application (2017-2028)
Figure 40. Global Antiblocking Agents Revenue Market Share by Application (2017-2028)
Figure 41. North America Antiblocking Agents Sales Market Share by Type (2017-2028)
Figure 42. North America Antiblocking Agents Revenue Market Share by Type (2017-2028)
Figure 43. North America Antiblocking Agents Sales Market Share by Application (2017-2028)
Figure 44. North America Antiblocking Agents Revenue Market Share by Application (2017-2028)
Figure 45. North America Antiblocking Agents Sales Share by Country (2017-2028)
Figure 46. North America Antiblocking Agents Revenue Share by Country (2017-2028)
Figure 47. United States Antiblocking Agents Revenue (2017-2028) & (US$ Million)
Figure 48. Canada Antiblocking Agents Revenue (2017-2028) & (US$ Million)
Figure 49. Europe Antiblocking Agents Sales Market Share by Type (2017-2028)
Figure 50. Europe Antiblocking Agents Revenue Market Share by Type (2017-2028)
Figure 51. Europe Antiblocking Agents Sales Market Share by Application (2017-2028)
Figure 52. Europe Antiblocking Agents Revenue Market Share by Application (2017-2028)
Figure 53. Europe Antiblocking Agents Sales Share by Country (2017-2028)
Figure 54. Europe Antiblocking Agents Revenue Share by Country (2017-2028)
Figure 55. Germany Antiblocking Agents Revenue (2017-2028) & (US$ Million)
Figure 56. France Antiblocking Agents Revenue (2017-2028) & (US$ Million)
Figure 57. U.K. Antiblocking Agents Revenue (2017-2028) & (US$ Million)
Figure 58. Italy Antiblocking Agents Revenue (2017-2028) & (US$ Million)
Figure 59. Russia Antiblocking Agents Revenue (2017-2028) & (US$ Million)
Figure 60. Asia Pacific Antiblocking Agents Sales Market Share by Type (2017-2028)
Figure 61. Asia Pacific Antiblocking Agents Revenue Market Share by Type (2017-2028)
Figure 62. Asia Pacific Antiblocking Agents Sales Market Share by Application (2017-2028)
Figure 63. Asia Pacific Antiblocking Agents Revenue Market Share by Application (2017-2028)
Figure 64. Asia Pacific Antiblocking Agents Sales Share by Region (2017-2028)
Figure 65. Asia Pacific Antiblocking Agents Revenue Share by Region (2017-2028)
Figure 66. China Antiblocking Agents Revenue (2017-2028) & (US$ Million)
Figure 67. Japan Antiblocking Agents Revenue (2017-2028) & (US$ Million)
Figure 68. South Korea Antiblocking Agents Revenue (2017-2028) & (US$ Million)
Figure 69. India Antiblocking Agents Revenue (2017-2028) & (US$ Million)
Figure 70. Australia Antiblocking Agents Revenue (2017-2028) & (US$ Million)
Figure 71. China Taiwan Antiblocking Agents Revenue (2017-2028) & (US$ Million)
Figure 72. Indonesia Antiblocking Agents Revenue (2017-2028) & (US$ Million)
Figure 73. Thailand Antiblocking Agents Revenue (2017-2028) & (US$ Million)
Figure 74. Malaysia Antiblocking Agents Revenue (2017-2028) & (US$ Million)
Figure 75. Latin America Antiblocking Agents Sales Market Share by Type (2017-2028)
Figure 76. Latin America Antiblocking Agents Revenue Market Share by Type (2017-2028)
Figure 77. Latin America Antiblocking Agents Sales Market Share by Application (2017-2028)
Figure 78. Latin America Antiblocking Agents Revenue Market Share by Application (2017-2028)
Figure 79. Latin America Antiblocking Agents Sales Share by Country (2017-2028)
Figure 80. Latin America Antiblocking Agents Revenue Share by Country (2017-2028)
Figure 81. Mexico Antiblocking Agents Revenue (2017-2028) & (US$ Million)
Figure 82. Brazil Antiblocking Agents Revenue (2017-2028) & (US$ Million)
Figure 83. Argentina Antiblocking Agents Revenue (2017-2028) & (US$ Million)
Figure 84. Middle East and Africa Antiblocking Agents Sales Market Share by Type (2017-2028)
Figure 85. Middle East and Africa Antiblocking Agents Revenue Market Share by Type (2017-2028)
Figure 86. Middle East and Africa Antiblocking Agents Sales Market Share by Application (2017-2028)
Figure 87. Middle East and Africa Antiblocking Agents Revenue Market Share by Application (2017-2028)
Figure 88. Middle East and Africa Antiblocking Agents Sales Share by Country (2017-2028)
Figure 89. Middle East and Africa Antiblocking Agents Revenue Share by Country (2017-2028)
Figure 90. Turkey Antiblocking Agents Revenue (2017-2028) & (US$ Million)
Figure 91. Saudi Arabia Antiblocking Agents Revenue (2017-2028) & (US$ Million)
Figure 92. UAE Antiblocking Agents Revenue (2017-2028) & (US$ Million)
Figure 93. Antiblocking Agents Value Chain
Figure 94. Antiblocking Agents Production Process
Figure 95. Channels of Distribution
Figure 96. Distributors Profiles
Figure 97. Bottom-up and Top-down Approaches for This Report
Figure 98. Data Triangulation
Figure 99. Key Executives Interviewed
